(BPT) - For him, it’s personal. In 2016 Milton “Todd” Ault III founded early clinical-stage biopharmaceutical company Alzamend Neuro with the mission of finding a cure for Alzheimer’s. Having witnessed the suffering of several family members with the disease and aware that little progress has been made toward treatment since Alzheimer’s discovery almost 100 years ago, Ault is committed to fast-tracking a cure. Coupling private sector investment with an Operation Warp Speed method to catalyze Big Pharma into action, Ault is working with proven Wall Street investors to raise funds and bring peace and resolution to patients and their families.
Print subscribers have FREE access to clevelandbanner.com by registering HERE
Non-subscribers have limited monthly access to local stories, but have options to subscribe to print, web or electronic editions by clicking HERE
We are sorry but you have reached the maximum number of free local stories for this month. If you have a website account here, please click HERE to log in for continued access.
If you are a print subscriber but do not have an account here, click HERE to create a website account to gain unlimited free access.
Non-subscribers may gain access by subscribing to any of our print or electronic subscriptions HERE